# Celine Halioua

Các tập podcast hàng đầu
Đã cập nhật:

Celine Halioua - Making dogs live longer so humans can too

Celine Halioua is the Founder & CEO of Loyal - the first company to ever receive FDA approval to develop a drug to extend lifespan in dogs, and they have raised $125mm from Bain Capital Ventures, Khosla Ventures, First Round and others to do so. By building a blockbuster longevity drug for dugs, Lo…

Unlocking Dog Longevity

Join host Jocelyn Kessler and co-host Mary Grace Kessler in this enlightening episode of Future Dog as we dive into the important topic of dog longevity and wellness. With a focus on how we can keep our beloved canine companions with us for longer, Jocelyn discusses the emotional toll of losing a p…

Celine Halioua On The Science and Business of Making Dogs Live Longer

Celine Halioua, Founder & CEO of Loyal, joins Village Global VP Sam Kirschner to discuss her journey building a biotech company developing the first FDA-approved drugs for lifespan extension – going dogs first. Loyal has raised over $250M and recently closed its Series C after clearing major regula…

Daniel Burger, Founder of Eightsix Science - Solving death through brain replacement

Daniel Burger is a neuroengineer and founder of EightSix Science, a company working to solve death as an engineering challenge. He recently raised funding from Tim Draper and is partnering with Japanese universities on cutting-edge brain tissue engineering. His background spans neuroengineering, or…

Why No One Talks Cournot, Hollywood vs. Seedance 2.0, Micron’s $200B Bet | Jon Caramanica, Haseeb Qureshi, Spenser Skates, Celine Halioua, Ankur Goyal, Reed Duchscher

Sign up for TBPN’s daily newsletter at TBPN.com (00:52) - Why is no one talking about the Cournot Equilibrium? (23:53) - 𝕏 Timeline Reactions (33:04) - Adani Group Unveils $100B AI Investment (35:31) - Micron Bets $200B to End AI Bottleneck (41:01) - Warner Bros Reopens Paramount Talks …

Loyal’s Celine Halioua: From Defying Doubters To Pioneering Dog Longevity

When Loyal founder Celine Halioua told people she was building a dog longevity startup, they laughed in her face. Now she's running what could be the largest-ever clinical trial to extend canine lifespans — pursuing FDA approval for multiple drugs to help senior and large dogs live two years longer…

[Highlight] Why Dog Longevity Drugs Are the Fastest Path to Human Longevity with Celine Halioua

This is a short excerpt from our full conversation with Celine Halioua, Founder & CEO of Loyal, which recently raised a $100M Series C, and Village Global GP Sam Kirschner.Celine discusses Loyal's 10-year vision for expanding into cats and humans, why the pharmaceutical industry has been slow to tr…

[Highlight] What Happens to Society When We Live to 100? with Celine Halioua

This is a short excerpt from our full conversation with Celine Halioua, Founder & CEO of Loyal, which recently raised a $100M Series C, and Village Global GP Sam Kirschner.Celine discusses what's still non-consensus in longevity, how cognitive aging shapes our preferences and worldviews, and what s…

57: This miracle pill could make dogs live longer, with Celine Halioua, Founder & CEO of Loyal

What if the biggest barrier to a longer life isn't science, but the economic incentives of corporations? In this episode of Onward, Ben sits down with Celine Halioua, founder and CEO of Loyal — the biotech company on track to earn the first-ever FDA approval for a drug whose only purpose is to ex…

638. Are You Ready for the Elder Swell?

In the U.S., there will soon be more people over 65 than there are under 18 — and it’s not just lifespan that’s improving, it’s “healthspan” too. Unfortunately, the American approach to aging is stuck in the 20th century. In less than an hour, we try to unstick it. (Part three of a three-part serie…